Bromelain compared with steroid gel for oral lichen planus
Compares bromelain, triamcinolone acetonide, and both together in people with oral lichen planus.
Key facts
- Who runs it
- Cairo University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Effect of Topical Bromelain Versus Topical Corticosteroids in the Management of Oral Lichen Planus
- Status
- Recruiting
- Phase
- Phase 2
- People taking part
- 42 people, planned
- Started
- 18 Feb 2026
- Planned end
- 15 Aug 2026
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Topical Bromelain
- 0.1% topical triamcinolone acetonide
- Combination of Topical Bromelain and Triamcinolone Acetonide in Orabase
- Record updated
- 9 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with oral lichen planus that causes symptoms. Oral lichen planus is a long-lasting inflammation inside the mouth.
- Sex
- All sexes can join.
- Disease stage
- Oral lichen planus that causes symptoms, with no other visible mouth sores.
- Earlier treatment
- No systemic treatment, such as steroids by mouth or injection, other drugs that calm the immune system, or anti-inflammatory painkillers (NSAIDs), for at least eight weeks. No medicine applied inside the mouth for at least four weeks before the study.
Main reasons for not taking part
- Any disease that affects the whole body
- Recent systemic steroids, immune-calming drugs or NSAIDs
- Recent medicines applied inside the mouth
- Pregnancy
- Breastfeeding
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Patients suffering from symptomatic OLP
- Patients free from any visible oral lesions other than OLP
- Patients who agreed to take the supplied interventions
- Patient who will agree to participate in the study
- Patients who will accept to sign the informed consent
Who cannot take part
- Treatment with any systemic treatment such as systemic steroids, other immunosuppressive drugs or non-steroidal anti-inflammatory drugs at least eight weeks
- Treatment with any oral topical medications for at least four weeks prior to the study
- Patients suffering from any systemic disease
- Pregnant and lactating mothers
This trial is currently available in Egypt.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Bromelain, an enzyme extract derived from pineapples, has shown promise due to its anti-inflammatory and wound-healing properties. However, its efficacy in treating oral mucosal ulcers remains unexplored. This study aims to provide clinical evidence on the efficacy of bromelain for managing OLP, potentially offering a safer and more effective treatment option.
The 3 groups in the trial
- Topical Bromelain in OrabaseTreatment being tested
Participants in this group will receive topical bromelain incorporated into an orabase. Patients will be instructed to apply the formulation four times daily No additional topical medications will be permitted.
Treatment: Topical Bromelain
- Topical Triamcinolone Acetonide in OrabaseExisting treatment, for comparison
This group will receive topical 0.1% triamcinolone acetonide The treatment will be applied four times daily, following the same instructions and precautions as in Arm 1
Treatment: 0.1% topical triamcinolone acetonide
- Combination of Topical Bromelain and Triamcinolone Acetonide in OrabaseTreatment being tested
Participants in this arm will be treated with a combination formulation containing both topical bromelain and 0.1% triamcinolone acetonide in orabase. Application instructions will be identical to those in the other arms: four times daily.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of Topical Bromelain Versus Topical Corticosteroids in the Management of Oral Lichen Planus : A Randomized Clinical Trial
- Plain-language title
- Bromelain compared with steroid gel for oral lichen planusGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 9 June 2026